CIK 0001478320
- Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- Operating
- EIN
- 270907024
- Phone
- +1 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $14,724,890
- in 17 filings, $14.5M under 10b5-1 plans
Net −$14,724,890. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-03-08 | BALDO LANCE Chief Medical Officer | Sale | −3,350 | $11.43 | $38K | 17,171 |
| 2022-03-07 | BALDO LANCE Chief Medical Officer | Sale | −2,373 | $12.01 | $28K | 20,521 |
| 2021-04-14 | BALDO LANCE Chief Medical Officer | Option exercise | +2,000 | $7.80 | $16K | 24,894 |
| 2021-04-14 | BALDO LANCE Chief Medical Officer | Sale | −2,000 | $44.50 | $89K | 22,894 |
| 2021-04-14 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −2,000 | 339,250 | ||
| 2021-03-04 | BALDO LANCE Chief Medical Officer | Grant or award | +22,894 | 22,894 | ||
| 2021-03-04 | BALDO LANCE Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +57,234 | 57,234 | ||
| 2021-01-27 | BALDO LANCE Chief Medical Officer | Option exercise | +40,000 | $7.80 | $312K | 40,000 |
| 2021-01-27 | BALDO LANCE Chief Medical Officer | Sale | −17,499 | $58.22 | $1.0M | 22,501 |
| 2021-01-27 | BALDO LANCE Chief Medical Officer | Sale | −14,233 | $59.24 | $843K | 8,268 |
| 2021-01-27 | BALDO LANCE Chief Medical Officer | Sale | −8,268 | $60.01 | $496K | 0 |
| 2021-01-27 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −40,000 | 341,250 | ||
| 2020-12-07 | BALDO LANCE Chief Medical Officer | Option exercise | +6,250 | $7.80 | $49K | 6,250 |
| 2020-12-07 | BALDO LANCE Chief Medical Officer | Sale | −780 | $48.79 | $38K | 5,470 |
| 2020-12-07 | BALDO LANCE Chief Medical Officer | Sale | −3,000 | $50.14 | $150K | 2,470 |
| 2020-12-07 | BALDO LANCE Chief Medical Officer | Sale | −2,470 | $51.26 | $127K | 0 |
| 2020-12-07 | BALDO LANCE Chief Medical Officer | Option exercise · Stock Option (Right to Buy) | −6,250 | 381,250 | ||
| 2020-11-06 | BALDO LANCE Chief Medical Officer | Option exercise | +6,250 | $7.80 | $49K | 6,250 |
| 2020-11-06 | BALDO LANCE Chief Medical Officer | Sale | −5,453 | $50.54 | $276K | 797 |
| 2020-11-06 | BALDO LANCE Chief Medical Officer | Sale | −797 | $51.26 | $41K | 0 |
Page 1 of 3 · 56 trades